Moderna said Thursday that its vaccine is 93% effective through six months after receiving the second dose. In a news release, the company added that it tested three booster shots in phase 2 of its ...
A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results